HRX-0233

CAT: 0931-T200053-01Size: 25 mgDry Ice: NoHazardous: No
CAT#:0931-T200053-01Size:25 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
2409140-12-9
Target
Ras|||MAPK|||Kras
Related Pathways
MAPK
Bioactivity
HRX-0233 is a small molecule inhibitor targeting MAP2K4. In vivo, HRX-0233 effectively reduces tumors in H358 KRASG12C mutant non-small cell lung cancer (NSCLC) without significant toxicity. This compound also prevents feedback activation of receptor tyrosine kinases (RTKs) when used as a monotherapy with the KRAS inhibitor Sotorasib, leading to more sustained and comprehensive inhibition of the MAPK signaling pathway. HRX-0233 holds potential for research in AR-negative prostate cancer, lung cancer, and colon cancer.
Smiles
O=C(C1=CC=C(F)C(NS(=O)(=O)CCC)=C1F)C2=CNC3=NC=C(C=C32)C=4C=NC(=NC4)C5CC5
Molecular Formula
C24H21F2N5O3S
Molecular Weight
497.52
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
T9901A-892-01SIM-0235
T73195-01EAPB 02303
T13192-01TPA-023B
T69793-01VEL-0230
T16767-01Ro-24-0238
T68175-01NF 023
T67804-01KM-023
T9901A-1032-01JCAR-023
T17144-01TPA 023
T86156-01DA-023

Alternative Products

CatalogName
HY-159190-01HRX-0233
M4127-01MLLN (HRX)
abx026166-01HRX Antibody
MBS602175-01MLLC (HRX)
MBS6242932-01MLLC (HRX) (Biotin)
MBS6244532-01MLLN (HRX) (PE)
MBS6243998-01MLLC (HRX) (HRP)
MBS6243465-01MLLC (HRX) (FITC)
MBS6243466-01MLLN (HRX) (FITC)
MBS6244531-01MLLC (HRX) (PE)

Popular Products